|

Anti-thymocyte globulin (ATG) Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Thymoglobulin

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • University of Florida1
  • City of Hope Medical Center1

Indications

  • Type 1 Diabetes2
  • Diabetes2
  • New Onset1

San Francisco, California1 trial

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

UCSF

Phase 1/2

Aurora, Colorado1 trial

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

Barbara Davis Center for Diabetes

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.